4307:TSENomura Research Institute,Ltd. Analysis
Data as of 2026-05-23 - not real-time
¥4,697.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Nomura Research Institute is trading above its 20‑day and 50‑day simple moving averages, while the 14‑day RSI hovers in neutral territory and the MACD shows a bullish divergence, suggesting short‑term momentum is modestly positive. Price action remains bounded between a solid support near 4,000 and resistance around 5,200, with volatility unusually high for the sector and a very low beta indicating limited market‑wide price swings. Investor sentiment is at extreme greed, yet the stock’s valuation metrics tell a different story.
Fundamentally, the company posted modest revenue growth and a thin profit margin, but operating margins remain negative and free cash flow is negative, raising concerns about earnings sustainability. The trailing P/E is dramatically above the industry average, and the discounted cash‑flow model values the shares well below the current market price, indicating the stock is likely overvalued. A payout ratio exceeding 200% and recent impairment charges further question dividend sustainability, while the firm’s strong cash reserves are offset by a sizable debt load.
Fundamentally, the company posted modest revenue growth and a thin profit margin, but operating margins remain negative and free cash flow is negative, raising concerns about earnings sustainability. The trailing P/E is dramatically above the industry average, and the discounted cash‑flow model values the shares well below the current market price, indicating the stock is likely overvalued. A payout ratio exceeding 200% and recent impairment charges further question dividend sustainability, while the firm’s strong cash reserves are offset by a sizable debt load.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- high trailing P/E relative to peers
- price above DCF fair value
- decreasing volume trend
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- stable revenue growth and strong cash base
- persistent operating losses
- overweight dividend payout
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- unsustainable dividend policy
- large impairment charges
- valuation gap suggesting downside risk
Key Metrics & Analysis
Financial Health
Revenue Growth8.00%
Profit Margin1.87%
P/E Ratio178.6
ROE3.60%
ROA3.79%
Debt/Equity54.04
P/B Ratio6.2
Op. Cash Flow¥147.6B
Free Cash Flow¥-21191000064
Industry P/E39.5
Technical Analysis
TrendNeutral
RSI55.7
Support¥4,054.00
Resistance¥5,224.00
MA 20¥4,540.30
MA 50¥4,480.38
MA 200¥5,364.65
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair Value¥3,107.39
Target Price¥5,730.00
Upside/Downside21.99%
GradeOvervalued
TypeGrowth
Dividend Yield1.79%
Risk Assessment
Beta0.29
Volatility58.40%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.